Recent reports indicate the emergence of a new carbapenemase producing Klebsiella pneumoniae clone, ST307. Here we show that ST307 emerged in the mid--1990s (nearly 20 years prior to its first report), is already globally distributed and is intimately associated with a conserved plasmid harbouring the bla CTX--M--15 extended-spectrum beta--lactamase (ESBL) gene plus other antimicrobial resistance determinants. Our findings support the need for enhanced surveillance of this widespread ESBL clone in which carbapenem resistance is now emerging.
was determined to be the best fit and we confirmed a strong temporal signal by date--randomisation and linear regression (Figure S1 ).
ST307 emerged in the mid--1990s and has disseminated globally
We estimate that ST307 emerged in 1994 (95% HPD, 1974 HPD, -2006 , close to the emergence date estimated previously for ST258 [17] , despite the fact that the latter was reported in the literature and recognised as a disseminated clone more than a decade earlier than ST307 [18] . The estimated mutation rate for ST307 (1.18x10 --6 substitutions site --1 year --1 , 95% HPD, 8.01x10 --7 -1.58x10 --6 ; Figure S1 ) was also remarkably similar to that estimated previously for ST258 [17] . The phylogeny revealed two deep--branching lineages, one of which has become globally distributed, comprising genomes from the Americas, Asia, Australia, the Middle East and Europe (Figure 2 ). Within this lineage there was evidence of transfer of ST307 between countries, and for all countries with >3 genomes there were multiple clusters within the global lineage. The countries with the highest representation were distributed most broadly (Norway, n=30; USA, n=22; UK, n=22), suggesting that the same patterns would likely be detected for most countries if sampling was increased (Figure 2) . The second lineage included only subsampled strains from Texas (2011--2015) , indicating that the majority of the hundreds of infections attributed to ST307 in [1] resulted from prolonged local transmission of this clade. Texan isolates were also found in the global lineage, suggesting that the USA may be a potential origin for ST307, as most of its genetic diversity was present in that location.
ST307 virulence and antimicrobial resistance genes
We used Kleborate [19] to investigate the prevalence of acquired AMR and virulence determinants and Kaptive [20] to investigate capsule (K) and lipopolysaccharide (O) locus diversity. We detected no evidence of the Kp virulence plasmid [21] , but a minority of genomes (n=12, 12.6%) harboured the yersiniabactin siderophore locus located within three distinct chromosomally integrated ICEKp variants. The distribution of ICEKp insertions on the ST307 core genome tree indicated >4 independent acquisitions with limited expansion of recipient sublineages (Figure 2) , consistent with the patterns recently reported for ST258 and other common MDR Kp clones [19] . Unlike those other clones [17, 22] , all ST307 shared the same capsule (KL107) and O antigen (O2v2) loci. An additional putative capsule synthesis locus (Kp616 genes C2861_20465 to C2861_20520 [2] ), which is unlike any known K--locus, was also conserved among ST307 but is rare among the broader Kp population (data not shown). In contrast to the virulence loci, acquired AMR genes were highly prevalent; 93 (97.9%) isolates carried acquired resistance determinants associated with ≥3 drug classes ( Table S2 ). The ParC 80I and GyrA 83I fluoroquinolone resistance--associated mutations were conserved in all genomes. The bla CTX--M--15 ESBL gene was found in 89 (93.7%) genomes, and 81 (85.3%) harboured it in combination with sul2, dfrA14 and strAB with/without aac(3)--IIa, which were all linked to an MDR plasmid (see below). bla KPCs and other AMR genes were occasionally identified (see Figure 2 and Table  S2 ). For the majority of genomes carrying bla CTX--M--15 (n=88/89) BLASTn confirmed that this gene was located downstream of ISEcp1, which forms a transposon to mobilise bla CTX--M--15 and promotes its expression [23] . Four complete ST307 IncFII K /IncFIB K bla CTX--M--15 plasmids have been published [2] , and share an insertion of the ISEcp1/bla CTX--M--15 transposon within Tn3. Read--mapping to pKPN3--307_typeA (accession KY271404) and assembly graph inspections of our bla CTX--M--15 --positive genomes showed that all carried the same ISEcp1/bla CTX--M--15 transposon. In 84/89 cases, the same pKPN3--307_typeA plasmid backbone was present and ISEcp1/bla CTX--M--15 was located in the same site within Tn3, consistent with conservation of the same ESBL plasmid (Figure S2) . The exceptions were: (i) an Australian isolate (13GNB--468) had the ISEcp1/bla CTX--M--15 transposon inserted in the chromosomal gene feoB; (ii) Kp616 carried no pKPN3--307_typeA--like plasmid but harboured bla CTX--M--15 on an IncN plasmid; and (iii) the five representatives of the Texan--specific lineage carried two chromosomal insertions of the ISEcp1/bla CTX--M--15 transposon (within Kp616 loci C2861_02545 and C2861_22795). This coupled with the additional GyrA 87N fluoroquinolone resistance mutation in the Texan lineage may have contributed to its prolonged transmission in the hospital setting. Regardless of these exceptions, the level of plasmid conservation in ST307 is remarkable, mirroring the association of ST258 with the bla KPC pKpQIL plasmid [17] and suggesting that the plasmid confers limited fitness cost to the host (although plasmid--positive, bla CTX--M--15 --negative genomes were observed, Table S2 ).
Conclusions
Complementing the increasing reports in the literature, our analyses reveal that ST307 is a highly successful MDR clone that shares many traits with ST258, but is closely associated with bla CTX--M--15 rather than bla KPCs . With sufficient exposure ST307 can acquire and disseminate carbapenemases [1] [2] [3] , and likely other clinically important AMR determinants. ST307 appears to be readily transferred between countries and has already become globally disseminated, yet has remained largely unnoticed for almost 20 years. These findings indicate an urgent need for enhanced surveillance of MDR Kp to monitor ST307 alongside other well--known clones and detect emerging MDR threats. 
